These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 9580645

  • 1. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes.
    Hartmann G, Krug A, Bidlingmaier M, Hacker U, Eigler A, Albrecht R, Strasburger CJ, Endres S.
    J Pharmacol Exp Ther; 1998 May; 285(2):920-8. PubMed ID: 9580645
    [Abstract] [Full Text] [Related]

  • 2. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
    Bennett CF, Chiang MY, Chan H, Shoemaker JE, Mirabelli CK.
    Mol Pharmacol; 1992 Jun; 41(6):1023-33. PubMed ID: 1352033
    [Abstract] [Full Text] [Related]

  • 3. Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
    Bennett CF, Mirejovsky D, Crooke RM, Tsai YJ, Felgner J, Sridhar CN, Wheeler CJ, Felgner PL.
    J Drug Target; 1998 Jun; 5(3):149-62. PubMed ID: 9606005
    [Abstract] [Full Text] [Related]

  • 4. Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.
    Kanamaru T, Takagi T, Takakura Y, Hashida M.
    J Drug Target; 1998 Jun; 5(4):235-46. PubMed ID: 9713974
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of Epstein Barr Virus LMP1 gene expression in B lymphocytes by antisense oligonucleotides: uptake and efficacy of lipid-based and receptor-mediated delivery systems.
    Galletti R, Masciarelli S, Conti C, Matusali G, Di Renzo L, Meschini S, Arancia G, Mancini C, Mattia E.
    Antiviral Res; 2007 May; 74(2):102-10. PubMed ID: 17382835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intracellular uptake of modified oligonucleotide studied by two fluorescence techniques.
    Kocisová E, Praus P, Rosenberg I, Seksek O, Sureau F, Stĕpánek J, Turpin PY.
    Biopolymers; 2007 May; 74(1-2):110-4. PubMed ID: 15137106
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides].
    Chen HL, Liang WQ, Shao JB, Chen Z.
    Yao Xue Xue Bao; 2004 Jan; 39(1):72-6. PubMed ID: 15127587
    [Abstract] [Full Text] [Related]

  • 15. Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
    Dinauer N, Lochmann D, Demirhan I, Bouazzaoui A, Zimmer A, Chandra A, Kreuter J, von Briesen H.
    J Control Release; 2004 May 18; 96(3):497-507. PubMed ID: 15120905
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset.
    Kronenwett R, Steidl U, Kirsch M, Sczakiel G, Haas R.
    Blood; 1998 Feb 01; 91(3):852-62. PubMed ID: 9446645
    [Abstract] [Full Text] [Related]

  • 19. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes.
    Nestle FO, Mitra RS, Bennett CF, Chan H, Nickoloff BJ.
    J Invest Dermatol; 1994 Oct 01; 103(4):569-75. PubMed ID: 7930684
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.